TickerFactsScreenerDevelopers

Opus Genetics, Inc. (IRD) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2008: $369.1K2009: $7.30M2010: $12.34M2011: $9.86M2012: $13.49M2013: $18.69M2014: $9.83M2015: $10.20M2016: $11.58M2017: $8.90M2018: $8.74M2021: $24.53M2022: $42.63M2023: $50.50M2024: $30.32M2025: $45.09M$45.09M
2008Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$45.09M+48.7%
2024$30.32M-40.0%
2023$50.50M+18.5%
2022$42.63M+73.8%
2021$24.53M—
2018$8.74M-1.7%
2017$8.90M-23.1%
2016$11.58M+13.5%
2015$10.20M+3.8%
2014$9.83M-47.4%
2013$18.69M+38.6%
2012$13.49M+36.8%
2011$9.86M-20.1%
2010$12.34M+69.1%
2009$7.30M+1877.1%
2008$369.1K—